Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignancies.
Blood Adv
; 8(15): 4066-4076, 2024 Aug 13.
Article
in En
| MEDLINE
| ID: mdl-38885481
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Immunotherapy, Adoptive
/
Hematologic Neoplasms
/
B-Cell Activation Factor Receptor
/
Receptors, Chimeric Antigen
Limits:
Humans
Language:
En
Journal:
Blood Adv
Year:
2024
Document type:
Article
Affiliation country:
Canada
Country of publication:
United States